Diabetes, Obesity and Metabolism
© John Wiley & Sons Ltd
Edited By: R. Donnelly
Impact Factor: 6.198
ISI Journal Citation Reports © Ranking: 2015: 13/133 (Endocrinology & Metabolism)
Online ISSN: 1463-1326
Recently Published Issues
DOM aims to provide authors of original submissions with a first decision, supported by at least two expert reviewer evaluations, within 30 days of manuscript submission. The figures below exclude manuscripts which are rejected (usually within 1 week) following internal review by the assigned editor. The journal accepts 18% of total submissions.
For manuscripts submitted in 2016 (1st July 2016-31 December 2016):
✮99% of original submissions received a first decision, accompanied by peer reviewer reports, within 30 days of manuscript submission.
✮ The average time from submission to first decision was 19 days
The Editor's Corner
Selected key papers. Each month. Free.
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly DPP-4 inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Ronald Goldenberg, et al.